The Challenges of Treating Lead Toxicity During the COVID-19 Pandemic

Mackenzie R Dreher,Ann Printy,Joel Davidson,Bruna Schneider,Andrew Neuhauser,James B Besunder,Martha G Blackford
DOI: https://doi.org/10.1542/peds.2024-067808K
2024-10-01
PEDIATRICS
Abstract:Despite decades of environmental reform, legacy lead is a persistent health hazard within communities. Secondary prevention with screening for childhood lead exposure typically occurs at the 12-month and 24-month well visits, and early identification of toxicity is of vital importance to reduce morbidity and mortality. Over the past few years, there have been multiple challenges impacting the management of lead toxicity, including the coronavirus disease 2019 pandemic, a national shortage of the chelation agent CaNa2EDTA, and housing-related concerns that may result in re-exposure of lead before lead abatement. This report identifies the importance of lead screening and limitations that a pandemic has placed on health care while emphasizing access to care and community resources needs to be a priority.
What problem does this paper attempt to address?